Pain: Clinical Trials

1,987 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1313 completed, 252 unknown, 170 terminated, 83 recruiting. 1987 Phase 3, 309 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 31987Completed 1313, Unknown 252, Terminated 170, Recruiting 83, Withdrawn 81, Not yet recruiting 43, Active not recruiting 26, Enrolling by invitation 10, Suspended 9
Phase 2309Completed 185, Unknown 55, Recruiting 21, Terminated 18, Withdrawn 12, Not yet recruiting 8, Enrolling by invitation 5, Active not recruiting 4, Suspended 1

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 1,987 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis
Phase 2 / Phase 3Not yet recruitingGenascence Corporation2402027-07-012026-09-21
Phase 3 Bunionectomy Study
CPL-01, saline placebo - Postoperative Pain, Bunion
Phase 3Not yet recruitingCali Pharmaceuticals LLC1122027-03-012026-10-21
Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2
SP-102, Placebo, Dexamethasone Sodium Phosphate 10 MG/ML - Lumbosacral Radicular Pain
Phase 3Not yet recruitingSemnur Pharmaceuticals, Inc.7552027-02-012026-09-09
"Evaluation of the Efficacy of Intravenous Lidocaine on Chronic Post-operative Pain in Patients Requiring Emergency Abdominal Surgery. A Multicentre, Randomised, Controlled, Double-blind Study."
Lidocain, Placebo - Chronic Pain
Phase 3Not yet recruitingNantes University Hospital2662027-01-152026-10-09
Dexmedetomidine for Invasive Ventilation In the NEOnate
Dexmedetomidine Injectable Solution, Glucose 5% Injectable Solution - Invasive Ventilation, Infant Pain
Phase 2 / Phase 3Not yet recruitingCentre Hospitalier Intercommunal Creteil2462027-01-012026-08-26
Safety of F14 Following Total Knee Replacement
F14 (sustained release celecoxib) - Analgesia
Phase 2 / Phase 3SuspendedArthritis Innovation Corporation1002027-01-012026-06-05
CBD Supplementation in Brazilian Jiu-Jitsu Athletes
CBD Isolate 100mg BID, Placebo - Pro and Anti Inflamatory Cytokines, Pain
Phase 2 / Phase 3Not yet recruitingAssociação Pan-Americana Multidisciplinar de Endocanabinologia1002027-01-012026-07-27
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
Tranexamic Acid, Placebo - Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Phase 3Not yet recruitingDave Bernholt1002026-11-012026-10-26
Effect of Nebulized Lignocaine on Emergence Agitation After Sevoflurane Anesthesia in Pediatric Patients Undergoing Tonsillectomy
Lidocaine, 0.9% Normal Saline - Emergence Agitation, Emergence Delirium
Phase 3Not yet recruitingAssiut University602026-11-012026-10-13
Interest of Cryotherapy in Reducing Pain During Radial Arterial Blood Sampling
Apllication of medical device ice pack, Apllication of cream - Chronic Respiratory Diseases
Phase 3Not yet recruitingUniversity Hospital, Brest2582026-11-012026-10-30
Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT
intermittent theta burst stimulation, LoveYourBrain Yoga Program - Chronic Low Back Pain, Musculoskeletal Pain
Phase 3Not yet recruitingVA Office of Research and Development2132026-10-302026-10-26
Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain
Product DNN.63.18.040, Tramal® - Acute Pain
Phase 3Not yet recruitingAche Laboratorios Farmaceuticos S.A.3702026-10-192026-10-19
Morphine or Ketamine for Analgesia
Ketamine hydrochloride, Morphine sulphate - Abdominal Pain, Isolated Extremity Fracture
Phase 3RecruitingColumbia University10102026-10-172026-10-20
Suzetrigine in TKA
Placebo, Suzetrigine - Total Knee Arthroplasty (TKA), Total Knee Arthroplasty \(TKA\)
Phase 3RecruitingHospital for Special Surgery, New York1482026-10-152026-10-13
Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1
Neridronate - Complex Regional Pain Syndrome Type I
Phase 3RecruitingAmbros Therapeutics, Inc.1352026-10-132026-10-16
Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department
20mg intranasal ketorolac, 30mg Intranasal Ketorolac - Pain, Ketorolac
Phase 3Not yet recruitingTehran University of Medical Sciences1002026-10-102026-09-16
Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue Contusions
S-Ibuprofen Gel 5%, Vehicle Topical Gel - Acute Pain Due to Trauma
Phase 3RecruitingAponia Laboratories, Inc.2402026-10-082026-11-12
The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients
Dextrose 50% Intravenous Solution, Lidocaine 1% Injectable Solution - Ehlers-Danlos Syndrome, Low Back Pain
Phase 3WithdrawnTulane University2026-10-052026-10-08
A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery
Combogesic® tablets, Acetaminophen 500mg, Placebo - Post Operative Pain, Acute
Phase 3Not yet recruitingAFT Pharmaceuticals, Ltd.1802026-10-012026-07-01

Showing 20 of 1987. Sign in to see all of them.

Narrower conditions

Pain, Postoperative (443)  ·  Chronic Pain (156)  ·  Low Back Pain (134)  ·  Agnosia (124)  ·  Acute Pain (110)  ·  Headache (101)  ·  Neuralgia (85)  ·  Osteoarthritis (78)  ·  Neoplasms (67)  ·  Migraine Disorders (63)  ·  Back Pain (58)  ·  Angina, Unstable (43)  ·  Abdominal Pain (42)  ·  Cancer Pain (41)

Broader conditions

Pathological Conditions, Signs and Symptoms (1987)  ·  Signs and Symptoms (1986)  ·  Neurologic Manifestations (1981)  ·  Pathologic Processes (629)  ·  Nervous System Diseases (466)  ·  Postoperative Complications (450)  ·  Musculoskeletal Diseases (260)  ·  Neuromuscular Diseases (206)  ·  Joint Diseases (154)  ·  Neurobehavioral Manifestations (140)  ·  Peripheral Nervous System Diseases (138)  ·  Vascular Diseases (138)  ·  Rheumatic Diseases (133)  ·  Cardiovascular Diseases (131)

Interventions

Acetaminophen (97)  ·  Morphine (87)  ·  Bupivacaine (82)  ·  Saline Solution (74)  ·  Lidocaine (70)  ·  Sodium Chloride (68)  ·  Pregabalin (63)  ·  Ketamine (60)  ·  Ibuprofen (57)  ·  Ropivacaine (54)  ·  Fentanyl (48)  ·  Oxycodone (46)  ·  Dexamethasone (38)  ·  Dexmedetomidine (31)  ·  Tramadol (31)

Sponsors

Pfizer (40)  ·  Assiut University (34)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (26)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (24)  ·  Assistance Publique - Hôpitaux de Paris (22)  ·  Purdue Pharma LP (22)  ·  Bayer (19)  ·  Jazz Pharmaceuticals (18)  ·  Grünenthal GmbH (17)  ·  Cairo University (16)  ·  Eli Lilly and Company (16)  ·  Endo USA Inc., a Keenova Therapeutics Company (15)  ·  Alza Corporation, DE, USA (13)  ·  Hospital General Universitario Elche (12)  ·  Pacira Pharmaceuticals, Inc (12)

Countries

United States (792)  ·  Canada (166)  ·  France (153)  ·  Germany (111)  ·  United Kingdom (105)  ·  Spain (92)  ·  Egypt (81)  ·  Poland (78)  ·  Brazil (75)  ·  Italy (70)  ·  Denmark (60)  ·  China (58)  ·  Belgium (52)  ·  Hungary (52)  ·  Netherlands (52)

Top investigators

Andrew Finn, PharmD (6)  ·  Anna Taddio, PhD (5)

Results publications

PMID 37460782, PMID 23340531, PMID 24985410, PMID 25526232, PMID 29476499, PMID 30936738, PMID 31284771, PMID 31387410, PMID 31482569, PMID 31952501, PMID 32576229, PMID 32621325, PMID 32945631, PMID 33963686, PMID 34264500, PMID 34878624, PMID 35076090, PMID 35978286, PMID 37523477, PMID 17825712, PMID 22900785, PMID 23709304, PMID 24353047, PMID 24916058, PMID 25565885, PMID 27448285, PMID 29492863, PMID 30462830, PMID 30594122, PMID 30737315, PMID 32871021, PMID 33069214, PMID 33143451, PMID 33544305, PMID 33549036, PMID 33950375, PMID 39316284, PMID 39428602, PMID 12424394, PMID 14977340, PMID 17180268, PMID 19546766, PMID 20353434, PMID 20521870, PMID 20920236, PMID 21208106, PMID 21519308, PMID 21521204, PMID 22437221, PMID 22587481

NIH funding

2014 (18), 2009 (15), 2015 (12), 2005 (9), 2008 (8), 2019 (7), 2023 (7), 2017 (6), 2018 (5), 2016 (4), U10CA037429 (4), 2025 (3), U10CA037404 (2), U10CA037420 (2), U10CA037447 (2)